Collectively, these findings suggest that UNC13B may regulate multiple oncogenic and apoptotic signaling pathways—such as those involving PINK1, CDK2, AKR7A3, and Bim—to promote cell survival and proliferation in multiple myeloma. This evidence concerns the gene BCL2L11 and plasma cell myeloma.